$LumiraDx (LMDXF.US)$
for those of you not on ST. SP will fly regardless

$LumiraDx (LMDXF.US)$ Lumiradx changing name to LKM INNOVATIONS and restructuring their finances? 🤔🤔🤔 ultimately Roche $ROCHE HOLDING AG (RHHBY.US)$  is in control but they still owe us 1.1B worse case scenario. I think this is what the dealio was with the shares transferring over. Let's hope Roche is on our side. I don't think they'd issue out their own directors and put this much effort in just to screw us holding shares. @BadPaint

$LumiraDx (LMDXF.US)$
someone send FTI an email asking about the 1.1 billion debt Roche owes shareholders, they won't respond because they think we don't know about the subscription transfer of 1002 shares that each share was worth approximately $10,000 each

$LumiraDx (LMDXF.US)$
someone send fti another email about the 1.1 billion owed to shareholders from subscription transfer of 1002 shares worth a billion

$LumiraDx (LMDXF.US)$ just give us $5 a share holy shit im sick of waiting for this bullshit

$LumiraDx (LMDXF.US)$ I think Petoss is on to something on ST. The Columbian Subsidiary is left unchecked and according to emails some folks got from E-Trade apparently 2 parties are involved here....I'm thinking RonZ is the other for ElectraDX. Plausible that Columbia will be used for that company.
I just wish the nonsense would stop.

$LumiraDx (LMDXF.US)$ **If a large company acquires a smaller company's assets and refuses to provide information to shareholders, it raises serious concerns.**
Here are some potential avenues for shareholders to seek information and protect their rights:
1. **Securities and Exchange Commission (SEC):**
   * **File a Complaint:** Shareholders can file a complaint with the SEC alleging that the acquiring company is not complying with disclosure requirements.
   * **Seek Investigation:** The SEC...

$LumiraDx (LMDXF.US)$ **If Roche were to return assets to Lumiradx, it could significantly impact the liquidation process and potentially benefit shareholders.**
Here are some potential scenarios:
1. **Resumption of Operations:** If Roche returns critical assets or technology, Lumiradx could potentially resume operations, either fully or partially. This could lead to increased value for the company and its shareholders.
2. **Increased Liquidation Proceeds:** Returning assets could increase the ...

$LumiraDx (LMDXF.US)$ **Considering Ron Zwanziger's history with Abbott and Alere, it's plausible that a deferred payment structure could be involved in the Lumiradx liquidation.**
Zwanziger's experience in complex corporate deals and his history with Abbott, a large multinational corporation, suggests that there might be strategic reasons for a delayed or staggered payment structure. This could be due to various factors, such as:
1. **Complex Financial Arrangements:** The liquidation process m...